Restriction of human herpesvirus 6B replication by p53

Journal of General Virology

Volumn 89, Issue 5, 2008, Pages 1106-1113

  Øter, Bodil ^a   Kofol Olsen, Emil ^a   Bundgaard, Bettina ^a   Höllsberg, Per ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PIFITHRIN ALPHA; PROTEIN P53; BENZOTHIAZOLE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; PIFITHRIN; TOLUENE;

APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL CYCLE ARREST; CELL STRAIN HCT116; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; CYTOPATHOGENIC EFFECT; EPITHELIUM CELL; GENETIC TRANSFECTION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B; NONHUMAN; NULL CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RESTRICTION; RNA PURIFICATION; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS PURIFICATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING; CELL LINE; DRUG ANTAGONISM; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B;

BENZOTHIAZOLES; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; ENZYME INHIBITORS; EPITHELIAL CELLS; HERPESVIRUS 6, HUMAN; HUMANS; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 44649171243     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83262-0     Document Type: Article

References (32)

1. Black, J. B., Lopez, C. & Pellett, P. E. (1992). Induction of host cell protein synthesis by human herpesvirus 6. Virus Res 22, 13-23.
2. Boutell, C. & Everett, R. D. (2004). Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner. J Virol 78, 8068-8077.
3. Boutolleau, D., Duros, C., Bonnafous, P., Caliola, D., Karras, A., Castro, N. D., Ouachée, M., Narcy, P., Gueudin, M. & other authors (2006). Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 35, 257-263.
4. Braun, D. K., Dominguez, G. & Pellett P. E. (1997). Human herpesvirus 6. Clin Microbiol Rev 10, 521-567.
5. 2 arrest after DNA damage. Science 282, 1497-1501.
6. Casavant N. C., Luo, M. H., Rosenke, K., Winegardner, T., Zurawska, A. & Fortunato, E. A. (2006). Potential role of p53 in the permissive life cycle of human cytomegalovirus. J Virol 80, 8390-8401.
7. De Bolle, L., Hatse, S., Verbeken, E., De, C. E & Naesens, L. (2004). Human herpesvirus 6 infection arrests cord blood mononuclear cells in G2 phase of the cell cycle. FEBS Lett 560, 25-29.
8. Di Luca, D., Katsafanas, G., Schirmer, E. C., Balachandran, N. & Frenkel, N. (1990). The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 175, 199-210.
9. Donati, D., Martinelli, E., Cassiani-Ingoni, R., Ahlqvist, J., Hou, J., Major, E. O. & Jacobson, S. (2005). Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 79, 9439-9448.
10. Fortunato, E. A. & Spector, D. H. (1998). p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72, 2033-2039.
11. Hall, C. B., Caserta, M. T., Schnabel, K. C., Long, C., Epstein, L. G., Insel, R. A. & Dewhurst S. (1998). Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 26, 132-137.
12. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
13. Hobbs, W. E. & DeLuca, N. A. (1999). Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICPO. J Virol 73, 8245-8255.
14. Kashanchi, F., Araujo, J., Doniger, J., Muralidhar, S., Hoch, R., Khleif, S., Mendelson, E., Thompson, J., Azumi, N. & other authors (1997). Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14, 359-367.
15. Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V. & Gudkov, A. V. (1999). A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737.
16. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
17. Martin, M. E. & Berk A. J. (1998). Adenovirus E1B 55K represses p53 activation in vitro. J Virol 72, 3146-3154.
18. Mocarski, E. S., Jr (2002). Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10, 332-339.
19. Øter, B. & Höllsberg, P. (2002). Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol 76, 7578-7586.
20. Øter, B., Bundgaard, B. & Höllsberg, P. (2005). Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J Virol 79, 1961-1965.
21. Øter, B., Kaspersen, M. D., Kofod-Olsen, E., Bundgaard, B. & Höllsberg, P. (2006). Human herpesvirus 6B inhibits cell proliferation by a p53-independent pathway. J Clin Virol 37, S63-S68.
22. Pedersen, S. M. & Höllsberg, P. (2006). Complexities in human herpesvirus-6A and -6B binding to host cells. Virology 356, 1-3.
23. Pedersen, S. M., Øter, B, Bundgaard, B. & Höllsberg, P. (2006). Induction of cell-cell fusion from without by human herpesvirus 6B. J Virol 80, 9916-9920.
24. Shin, Y. C., Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T. F. & Jung, J. U. (2006). Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80, 2257-2266.
25. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T. & other authors (2003). Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523.
26. Takemoto, M., Mori, Y., Ueda, K., Kondo, K. & Yamanishi, K. (2004). Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol 85, 869-879.
27. Takemoto, M., Koike, M., Mori, Y., Yonemoto, S., Sasamoto, Y., Kondo, K., Uchiyama, Y. & Yamanishi, K. (2005). Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J Virol 79, 13037-13046.
28. Vogelstein, B., Lane, D. & Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
29. Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R. & Harris, C. C. (1994). Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A 91, 2230-2234.
30. Wei, C. L., Wu, O., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y. & other authors (2006). A global map of p53 transcription-factor binding sites in the human genonic. Cell 124, 207-219.
31. Wing, B. A., Johnson, R. A. & Huang, E. S. (1998). Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J Virol 72, 1814-1825.
32. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. & Kurata, T. (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1, 1065-1067.